Carcinogenicity of radiation doses caused by the Chernobyl fall-out in Sweden, and prevention of possible tumors
Tóm tắt
The fallout from the Chernobyl reactor resulted in radioactive fall-out in eeastern Sweden leading to a ground radiation intensity of between 2 and 500 μR h−1 above the 10–15 μR h−1 background, an average external cumulative dose of about 3–4 mSv (0.3–0.4 rem) to about 1 million people, or about 3500 man-Sv (350,000 man-rem) over 50 years, or 70 man-Sv per year with a maximum dose to a few individuals of 40 mSv. The corresponding figures reported for civilians around Chernobyl is 8.6 million man-rem in 1986 and 29 million man-rem over 50 years, or 600,000 man-rem (equivalent to about 6000 man-Sv) per year. If Swedish doses are averaged over the whole population, the average is about 1 mSv or 10,000 man-Sv, or 200 man-Sv per year. The thyroid uptake of131I is approximately 0.1–0.2 kBq (0.005 μCi) and the total body uptake of137Cs, 1 kBq (0.03 μCi), resulting in an approximate internal dose of 0.02 mSv. If a linear dose-response curve is assumed,an increase of the normal cancer mortality incidence in the million Swedes affected by 3500 man-Sv per 50 years from 200,000 to about 200,070 can be assumed. Corresponding figures for all of Sweden are 8,000,000 inhabitants, 7000 man-Sv, 1,720,000 normal cancer deaths, and 1,720,140 expected cancer deaths. Corresponding figures reported for the population outside the 30 km evacuation zone around Chernobyl are 300,000 man-Sv, and an increase from 6,800,000 cancer deaths per 50 years to 6,806,000 cancer deaths.
Tài liệu tham khảo
Upton A C: Biological aspects of radiation carcinogenesis, inBoice J D, Fraumeni J D (eds).Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 9. New York, Raven Press (1983).
Goodhead D T: Deductions from cellular studies of inactivation, mutagenesis, and transformation, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 369. New York, Raven Press (1984).
Gould M N: Radiation initiation of carcinogenesisin vivo: a rare or common cellular event, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 347. New York, Raven Press (1984).
Beebe G W: Developments in assessing carcinogenic risks from radiation, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological significance, p. 457. New York, Raven Press (1984).
Rothman K J: Significance of studies of low-dose radiation fallout in the Western United States, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 73. New York, Raven Press (1984).
Monson R R, MacMahon B: Prenatal X-ray exposure and cancer in children, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 97. New York, Raven Press (1984).
MacMahon B, Hutchinson G B: Prenatal X-ray and childhood cancer.Acta Unio Int Contra Cancrum 20, 1172 (1964).
Finch S C: Leukemia and lymphoma in atomic bomb survivors, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 37. New York, Raven Press (1983).
Howe G R: Epidemiology of radiogenic breast cancer, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 119. New York, Raven Press (1983).
National Academy of Sciences:The Effects in Populations of Exposure to Low Levels of Radiation. Washington National Academy of Sciences Press (1980).
Katz H, Schull W: Studies of the mortality of A-bomb survivors—7. Mortality 1950–1978: Part 1. Cancer mortality.Radiat Res 90, 395 (1982).
Stewart A, Webb J, Hewitt M A: A survey of childhood malignancies.Br Med J 1, 1495 (1958).
British Radiological Protection Association: The irradiation of volunteers in medical research.Br Med J 1, 7 (1976).
Use of ionizing radiation and radionuclides on human beings for medical research. Training and non-medical purposes. Tech. Rept. Series 611, Geneva, World Health Organisation (1977).
Shore R E, Woodward E D, Hempelmann L H: Radiation-induced thyroid cancer, in Boice J D, Fraumeni J F (eds):Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 131. New York, Raven Press (1984).
Modan B: Radiation-induced head and neck tumors.Lancet i, 277 (1974).
Schull W J: Atomic bomb survivors: patterns of cancer risks, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 21. New York, Raven Press (1983).
Gibson R: Irradiation in the epidemiology of leukemia among adults.J Natl Cancer Inst 48, 301 (1972).
Green M H: Interaction between radiotherapy and chemotherapy in human leukomogenesis, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 129. New York, Raven Press (1984).
Linos A, Gray J E, Orvis A L, Kyle R A O’Fallon W M, Kurland L T: Low-dose radiation and leukemia.New Engl J Med 302, 1101 1980.
Lyon L J, Gardner J W, West D W, Schussman L: Further information on the association of childhood leukemias with atomic fallout, in Enström J E: The nonassociation of fallout radiation with childhood leukemia in Utah, inBanbury Report: 4. Cancer Incidence in Defined Populations, pp. 147–186. Cold Spring Harbour (1980).
Matanoski G M, Sartwell P, Elliot E, Tonascia J, Sternberg A: in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 83. New York, Raven Press (1983).
van Kaick G, Muth H, Kaul A, Immich H, Liebermann D, Lorenz D, Lorenz W J, Lührs H, Scheer K E, Wagner G, Wegener K, Wesch H: Results of the German thorotrast study, in Boice J D Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 253. New York, Raven Press (1984).
Russel J G B: How much can the NHS afford to spend to save a life or avoid a severe disability?Lancet i, 281 (1985).
Holm L E: Thyroid cancer after exposure to radioiodine, inDie Hypothesen im Strahlenschutz, pp. 35–56. Stuttgart, Thieme (1985).
Holm L E, Dahlqvist I, Engs N, Israelsson A, Lungdell G: Malignant thyroid tumors after iodine-131 therapy.New Engl J Med 303, 188 (1980).
Holm L E, Lundell G, Walinder G: Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. I. Retrospective cohort study.J Natl Cancer Inst 64, 1056 (1980).
Holm L E, Eklund G, Lundell G: Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. II. Estimation of thyroid gland size, thyroid radiation dose, and predicted versus observed number of malignant thyroid tumors.J Natl Cancer Inst 65, 1221 (1980).
Holm L E: Malignant disease following iodine-131 therapy in Sweden, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 263. New York, Raven Press (1984).
Holm L E: Carcinogenic and genetic risks of ionizing radiation with special reference to radioiodines, in Beckers C. (ed):Thyroid Diseases, p. 159 (1982).
Pochin J E: Leukaemia following radioiodine treatment of thyrotoxicosis.Br Med J 2, 1545 (1960).
Boice J D, Day N E, Andersen Aet al.: Cancer risk following radiotherapy of cervical cancer, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 161. New York, Raven Press (1984).
Wagoner J K: Leukemia and other malignancies following radiation therapy for gynecological disorders, in Boice J D, Fraumeni J F (eds):Progress in Cancer Research and Therapy, Vol. 26,Radiation Carcinogenesis: Epidemiology and Biological Significance, p. 153 New York, Raven Press (1984).
Thakur M L, McAfee J G: The significance of chromosomal abberations in indium-111-labeled lymphocytes.J Nucl Med 25, 922 (1984).
Najean Y, Dresch C: in Mathé G, Reizenstein P (eds):Clinical Trials in Oncology: Methods, Errors, Ethics, and Results, Geneva Bioscience Ediprint (1986).
Tubiana M: Paper given at EORTC Plenary Meeting, Paris (1983).
Tamplin A [in Swedish]:Dagens Nyheter (Swedish Daily) (1986).
Ringdén O, Båryd I, Johansson B, Bolme P, Gahrton G, Groth C G, Klintmalm G, Lundgen G, Lönnqvist B: Increased mortality in bone marrow transplant recipients accidentally receiving an increased dose rate of total body irradiation.Ann Mtg Eur Bone Marrow Transpl Group 9 (1983) (suppl. toExp Hemat).
Reizenstein P: Stencilled information to Swedish medical personnel, 5 and 21 May (1986).
Reizenstein P, Larsson S, Ekman M, Stenke L: in preparation.
Lindell B, Beninson D: Chernobyl reactor accident. Provisional report of a WHO consultation 6 May 1986 (stencilled) KP/CEH 129.
Horisberger N, Hasselgren A, Jolly D, Reizenstein Pet al.: Summary report of a WHO working group on the impact of medical decision-making on hospital cost. (stencilled) ICP/PHC 601/m01(S) 15 April (1986).
Larsson L G, Bengtsson G, Walinder G: Radiation and health risks (in Swedish). IVA Beijer symp. 28 August 1986 (stencil).
Date on operational and emergency staff of the nuclear power plant who were exposed to radiation: size of the doses received and consequences for health. Annex 7 to draft of IAEA Safety Series Publication:Medical Handling of Accidentally Exposed Individuals, IAEA Technical Committee, Paris 27 October 1986 (stencil).
Greene M H, Harris E L, Gerhenson D Met al.: Melphalan may be a more potent leukemogen than cyclophosphamide.Ann Intern Med 105, 360 (1986).